Extracellular matrix and microvascularization regulatory genes in the mare placenta.

Overview

• This study investigates how certain genes involved in regulating the extracellular matrix (ECM) and blood vessel formation are controlled in the placenta of pregnant mares, focusing on gene activity, protein expression, and DNA methylation patterns.

Background

• The extracellular matrix (ECM) provides structural support to tissues and its composition is crucial for proper placental function.
• Collagen is a key component of the ECM, and its deposition is regulated by enzymes called matrix metalloproteinases (MMPs) and their inhibitors (TIMPs).
• Vascularization, or blood vessel formation, is essential for nutrient and oxygen transport in the placenta and is regulated by vascular endothelial growth factor (VEGF) and its receptors (VEGFR1, VEGFR2).
• Epigenetic modifications, such as DNA methylation, can regulate gene expression without altering the underlying DNA sequence.
• Understanding how these genes are regulated in the placenta can provide insights into mechanisms ensuring healthy pregnancy in mares.

Objectives of the Study

• To examine gene transcription and protein expression of enzymes that regulate collagen deposition—specifically MMP2, MMP9—and their inhibitors TIMP1 and TIMP2 in the placenta.
• To analyze gene transcription of VEGF-A and its receptors VEGFR1 and VEGFR2 to understand microvascular regulation.
• To investigate the methylation patterns in the promoter regions of MMP2, TIMP1, and TIMP2 genes in both pregnant and non-pregnant horns of the mare placenta.

Methodology

• Samples from 17 mares’ placentas were collected, comparing both the pregnant horn (PH) and the non-pregnant horn (NPH).
• Gene transcription levels were quantified using quantitative polymerase chain reaction (qPCR).
• Protein abundance was assessed via Western blotting to measure MMPs and TIMPs levels.
• Immunohistochemistry was used to localize specific proteins within placental tissues.
• DNA methylation of CpG islands in gene promoter regions was analyzed using bisulfite pyrosequencing.

Key Findings

• Gene transcription of MMP2, TIMP1, and TIMP2 was significantly higher in the pregnant horn (PH) compared to the non-pregnant horn (NPH).
• No significant differences were detected in gene transcription levels of MMP9, VEGFA, VEGFR1, or VEGFR2 between PH and NPH.
• Higher transcription of MMP2, TIMP1, and TIMP2 in PH correlated with hypomethylation (lower levels of DNA methylation) of their promoter regions, suggesting reduced epigenetic suppression.
• Conversely, decreased transcription in NPH was associated with promoter hypermethylation (higher methylation), implying greater gene silencing.
• Correlations between methylation and transcription were complex: in PH, MMP2 transcription correlated positively with methylation, while in NPH, MMP2, TIMP1, and TIMP2 showed negative correlations.
• Despite transcriptional differences, protein levels of MMP-2, MMP-9, TIMP-1, and TIMP-2 were similar between pregnant and non-pregnant horns.
• The ratio of MMP to TIMP proteins (MMP-2/TIMP-2 and MMP-9/TIMP-1) did not differ significantly between the two horns.
• Immunohistochemistry localized MMP-2, MMP-9, TIMP-1, and VEGF-A proteins primarily in trophoblast cells, while TIMP-2 was found in the stroma of the chorioallantoic membrane.

Interpretation and Significance

• The study suggests an epigenetic regulatory mechanism—specifically DNA methylation—modulates expression of genes that control ECM remodeling enzymes in the mare placenta.
• The hypomethylation-associated upregulation of MMP2, TIMP1, and TIMP2 in the pregnant horn likely supports ECM remodeling required for the developing fetus.
• Stable protein levels despite transcriptional changes indicate possible post-transcriptional or translational regulation to maintain balance of ECM remodeling enzymes.
• Similar VEGF-related gene expression suggests vascularization regulation may not differ significantly between placental horns late in pregnancy, or may be regulated by other mechanisms.
• The localization of these proteins to trophoblast cells and stroma highlights their functional roles in maintaining placental structure and function.
• Understanding these mechanisms could help in addressing placental dysfunctions related to abnormal ECM remodeling or vascularization in mares.

Conclusion

• This research identifies DNA methylation as an important epigenetic factor regulating the transcription of ECM-related genes in the equine placenta.
• These findings improve understanding of the molecular and epigenetic controls of placental development and maintenance in mares at term.
• Future studies may explore how disruptions in these regulatory pathways affect placental health and pregnancy outcomes.